Therapeutic oligonucleotides /
This book provides a comprehensive overview of the development of therapeutic oligonucleotides for therapeutic applications, touching on a number of additional oligonucleotides including a number of small interfering RNAs currently in various phases of clinical development. Written by leading expert...
| Other Authors: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Cambridge :
RSC Pub.,
[2008]
|
| Series: | RSC biomolecular sciences.
|
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
Table of Contents:
- The role of backbone modifications in oligonucleotide-based strategies
- Genasense (G3139) : an antisense Bcl-2 oligodeoxyribonucleotide with substantial clinical activity and a complex mechanism of action
- Antisense morpholino oligomers and their peptide conjugates
- Peptide-peptide nucleic acid conjugates for modulation of gene expression
- Locked nucleic acid: properties and therapeutic aspects
- Immune stimulatory oligonucleotides
- Decoy oligodeoxynucleotides to treat inflammatory diseases
- AS1411 : development of an anticancer aptamer
- Spiegelmer NOX-E36 for renal diseases
- Strategies for the delivery of oligonucleotides in vivo
- Lipid-mediated in vivo delivery of small interfering RNAs
- Vector-mediated and viral delivery of short hairpin RNAs
- Development of an RNAi-based gene therapy against HIV-1
- RNA based therapies for treatment of HIV infection.